Michael S. Wyzga is an American businessperson who has been the head of 6 different companies. Currently, he occupies the position of Independent Chairman for X4 Pharmaceuticals, Inc., Chairman at Gensight Biologics SA, President of Bioleap, Inc. (Florida) and CFO & Independent Non-Executive Director at Mereo BioPharma Group Plc. Michael S. Wyzga is also on the board of EXACT Sciences Corp., International Institute of New England, Inc., Dohmen Co. and LogicBio Therapeutics, Inc.
In his past career Mr. Wyzga occupied the position of President, Chief Executive Officer & Director at Radius Health, Inc., Chief Financial Officer of Kew, Inc., Chief Financial Officer for Aura Biosciences, Inc., Chief Financial Officer & Vice President of CacheLink Corp., Chairman for Arsanis, Inc., Chairman of X4 Pharmaceuticals, Inc., Chief Financial Officer & Executive Vice President of Genzyme Corp., Vice President-Finance at Lotus Development Corp., Chief Financial Officer at Sovereign Hill Software, Inc. and Principal at Digital Equipment Corp.
Michael S. Wyzga received an undergraduate degree from Suffolk University and an MBA from Providence College.